FDA Warning Letter — Quadrant Sales & Marketing, Inc.
The FDA took a Warning Letter action against Quadrant Sales & Marketing, Inc. on May 28, 2020 (Clearwater, FL). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Quadrant Sales & Marketing, Inc.
- Date
- May 28, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Clearwater, FL (United States)